Patent ID: 7494983
Filing Date: 2009-02-24
Classification: A61P,C07D

Abstract:
1. A compound of the structural formula I: or a pharmaceutically acceptable salt, in vivo hydrolysable ester, enantiomer, diastereomer or mixture thereof: wherein, R represents hydrogen, or C R R X represents —(CHR Y represents —CO(CH Q represents N, or O, wherein R R R R or, R R  represents phenyl, napthyl, phenanthrenyl, pyridyl, said phenyl, napthyl, phenanthrenyl, pyridyl optionally substituted with 1-3 groups selected from R Z represents (CH R* represents hydrogen, or C R R R said alkyl, alkenyl, alkoxy, heterocyclyl and aryl optionally substituted with 1-3 groups selected from C Z g is 0-1; m is 0-3; n is 0-3; and p is 0-3.